DiaMedica Therapeutics, Inc. (DMAC)
6.36
+0.04
(+0.63%)
USD |
NASDAQ |
May 11, 12:46
DiaMedica Therapeutics Market Cap : 342.70M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IN8bio, Inc. | 7.400M |
| Calidi Biotherapeutics, Inc. | 2.134M |
| ACADIA Pharmaceuticals, Inc. | 3.783B |
| Alnylam Pharmaceuticals, Inc. | 38.76B |
| Amgen, Inc. | 177.72B |
Market Cap Related Metrics
| PEG Ratio | -0.9788 |
| Price to Book Value | 7.255 |
| Price | 6.36 |
| Earnings Yield | -11.09% |
| PEGY Ratio | -0.9788 |